Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -21.51% is 88% below its 5-year average of -11.45%, near the high end of its 5-year range (-123.63%–1.51%).
As of the fiscal period ended Sunday, May 31, 2026. 17.08% below its 12-month average of -18.37%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-05-31): -21.51%.
RETURN ON EQUITY (ROE)
-21.51%
RETURN ON EQUITY (ROE) AVG TTM
-18.37%
RETURN ON EQUITY (ROE) AVG 3Y
-42.43%
RETURN ON EQUITY (ROE) AVG 5Y
-11.45%
RETURN ON EQUITY (ROE) AVG 10Y
-10.01%
RETURN ON EQUITY (ROE) AVG 15Y
-4.20%
RETURN ON EQUITY (ROE) AVG 20Y
-2.51%
CURRENT VS TTM AVG
-17.08%
CURRENT VS 3Y AVG
+49.31%
CURRENT VS 5Y AVG
-87.84%
CURRENT VS 10Y AVG
-114.84%
CURRENT VS 15Y AVG
-412.04%
CURRENT VS 20Y AVG
-758.30%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 753 covered companies
CURRENT VS SECTOR MEDIAN
+48.80%
vs the sector median at left
AngioDynamics, Inc.
Market Cap
$596.01M
Return on Equity (ROE)
-21.51%
TTM Avg
-18.37%
3Y Avg
-42.43%
5Y Avg
-11.45%
Market Cap
$597.55M
Return on Equity (ROE)
N/A
TTM Avg
-4.73%
3Y Avg
76.70%
5Y Avg
93.92%
Market Cap
$584.48M
Return on Equity (ROE)
-8.42%
TTM Avg
-4.61%
3Y Avg
-3.17%
5Y Avg
11.46%
Market Cap
$583.31M
Return on Equity (ROE)
-11.56%
TTM Avg
-11.05%
3Y Avg
-6.83%
5Y Avg
-8.10%
Market Cap
$611.57M
Return on Equity (ROE)
-24.06%
TTM Avg
-36.09%
3Y Avg
-34.99%
5Y Avg
-44.03%
Market Cap
$578.40M
Return on Equity (ROE)
N/A
TTM Avg
161.13%
3Y Avg
93.89%
5Y Avg
96.07%
Market Cap
$619.15M
Return on Equity (ROE)
-97.31%
TTM Avg
-116.17%
3Y Avg
-82.05%
5Y Avg
-65.68%
Market Cap
$571.13M
Return on Equity (ROE)
40.62%
TTM Avg
9.52%
3Y Avg
-25.24%
5Y Avg
-32.61%
Market Cap
$630.63M
Return on Equity (ROE)
-17.01%
TTM Avg
-22.91%
3Y Avg
-17.12%
5Y Avg
-14.58%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AngioDynamics, Inc. (ANGO) | $596.01M | -21.51% | -18.37% | -42.43% | -11.45% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $597.55M | N/A | -4.73% | 76.70% | 93.92% |
| Fulgent Genetics, Inc. (FLGT)vs › | $584.48M | -8.42% | -4.61% | -3.17% | 11.46% |
| OrthoPediatrics Corp. (KIDS)vs › | $583.31M | -11.56% | -11.05% | -6.83% | -8.10% |
| Climb Bio, Inc. (CLYM)vs › | $611.57M | -24.06% | -36.09% | -34.99% | -44.03% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $578.40M | N/A | 161.13% | 93.89% | 96.07% |
| SOPHiA GENETICS S.A. (SOPH)vs › | $619.15M | -97.31% | -116.17% | -82.05% | -65.68% |
| CorMedix Inc. (CRMD)vs › | $571.13M | 40.62% | 9.52% | -25.24% | -32.61% |
| OmniAb, Inc. (OABI)vs › | $630.63M | -17.01% | -22.91% | -17.12% | -14.58% |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
ROE
-21.5%
ROA
-13.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-05-31 | -21.51% |
| 2026-02-28 | -18.11% |
| 2025-11-30 | -15.71% |
| 2025-08-31 | -17.95% |
| 2025-05-31 | -18.58% |
| 2025-02-28 | -22.27% |
| 2024-11-30 | -120.32% |
| 2024-08-31 | -123.63% |
| 2024-05-31 | -89.67% |
| 2024-02-29 | -87.96% |
| 2023-11-30 | -3.52% |
| 2023-08-31 | 1.51% |
| 2023-05-31 | -13.86% |
| 2023-02-28 | -9.37% |
| 2022-11-30 | -8.02% |
| 2022-08-31 | -7.87% |
| 2022-05-31 | -6.25% |
| 2022-02-28 | -9.25% |
| 2021-11-30 | -8.87% |
| 2021-08-31 | -7.86% |
| 2021-05-31 | -7.18% |
| 2021-02-28 | -37.18% |
| 2020-11-30 | -37.71% |
| 2020-08-31 | -37.31% |
| 2020-05-31 | -36.59% |
| 2020-02-29 | -3.82% |
| 2019-11-30 | -2.74% |
| 2019-08-31 | -1.95% |
| 2019-05-31 | -1.81% |
| 2019-02-28 | 0.82% |
| 2018-11-30 | 3.24% |
| 2018-08-31 | 2.92% |
| 2018-05-31 | 3.01% |
| 2018-02-28 | 0.25% |
| 2017-11-30 | -1.88% |
| 2017-08-31 | 0.71% |
| 2017-05-31 | 0.97% |
| 2017-02-28 | -4.74% |
| 2016-11-30 | -5.25% |
| 2016-08-31 | -8.10% |
| 2016-05-31 | -8.60% |
| 2016-02-29 | -0.24% |
| 2015-11-30 | -1.13% |
| 2015-08-31 | -0.82% |
| 2015-05-31 | -0.60% |
| 2015-02-28 | -0.73% |
| 2014-11-30 | 0.89% |
| 2014-08-31 | 0.60% |
| 2014-05-31 | 0.44% |
| 2014-02-28 | 0.56% |
| 2013-11-30 | -0.47% |
| 2013-08-31 | -0.05% |
| 2013-05-31 | -0.12% |
| 2013-02-28 | -1.28% |
| 2012-11-30 | -1.43% |
| 2012-08-31 | -1.37% |
| 2012-05-31 | -0.97% |
| 2012-02-29 | 0.26% |
| 2011-11-30 | 1.62% |
| 2011-08-31 | 1.86% |
| 2011-05-31 | 2.00% |
| 2011-02-28 | 3.14% |
| 2010-11-30 | 3.06% |
| 2010-08-31 | 3.06% |
| 2010-05-31 | 3.15% |
| 2010-02-28 | 2.97% |
| 2009-11-30 | 2.64% |
| 2009-08-31 | 2.61% |
| 2009-05-31 | 2.67% |
| 2009-02-28 | 2.05% |
| 2008-11-30 | 2.90% |
| 2008-08-31 | 2.98% |
| 2008-05-31 | 3.06% |
| 2008-02-29 | 3.76% |
| 2007-11-30 | -2.31% |
| 2007-08-31 | -2.54% |
| 2007-05-31 | -2.72% |
| 2007-03-03 | -3.02% |
| 2006-02-25 | 11.33% |
| 2005-05-28 | 9.26% |
| 2005-02-26 | 9.79% |
